BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Ponce Financial Group
PDLB
$496M
| $2.87M | ﹤0.01% |
310,832
+102,458
| +49% | +$996K |
|
3877
Innovative Solutions & Support
ISSC
$348M
| $2.86M | ﹤0.01% |
397,919
-7,217
| -2% | -$57.5K |
|
3878
Kenon Holdings
KEN
$3.45B
| $2.86M | ﹤0.01% |
71,803
-7,742
| -10% | -$428K |
|
|
CTV
3879
DELISTED
Innovid Corp.
CTV
| $2.86M | ﹤0.01% |
1,722,168
+1,065,719
| +162% | +$4.58M |
|
|
CODX
3880
Co-Diagnostics
CODX
$5.45M
| $2.81M | ﹤0.01% |
16,721
+472
| +3% | +$71.8K |
|
|
AUY
3881
DELISTED
Yamana Gold, Inc.
AUY
| $2.81M | ﹤0.01% |
604,958
-10,352
| -2% | -$56.1K |
|
|
GHL
3882
DELISTED
Greenhill & Co., Inc.
GHL
| $2.81M | ﹤0.01% |
304,611
-1,833,483
| -86% | -$22.5M |
|
3883
Aehr Test Systems
AEHR
$2.99B
| $2.81M | ﹤0.01% |
374,237
-3,886
| -1% | -$32.3K |
|
|
PBPB
3884
DELISTED
Potbelly
PBPB
| $2.81M | ﹤0.01% |
496,349
-5,812
| -1% | -$34K |
|
|
USAK
3885
DELISTED
USA Truck Inc
USAK
| $2.81M | ﹤0.01% |
89,267
-739
| -0.8% | -$12.7K |
|
|
KLR
3886
DELISTED
Kaleyra, Inc.
KLR
| $2.8M | ﹤0.01% |
392,521
+390,306
| +17,621% | +$5.73M |
|
|
AMTI
3887
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $2.8M | ﹤0.01% |
961,466
-1,092,106
| -53% | -$4.59M |
|
3888
UroGen Pharma
URGN
$1.88B
| $2.79M | ﹤0.01% |
340,412
-1,360,364
| -80% | -$9.34M |
|
3889
LG Display
LPL
$3.07B
| $2.79M | ﹤0.01% |
499,084
-280,296
| -36% | -$1.9M |
|
|
LUNA
3890
DELISTED
Luna Innovations Incorporated
LUNA
| $2.78M | ﹤0.01% |
477,282
-1,407,323
| -75% | -$8.3M |
|
3891
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
| $2.78M | ﹤0.01% |
55,601
+34,526
| +164% | +$1.85M |
|
3892
Prelude Therapeutics
PRLD
$350M
| $2.76M | ﹤0.01% |
529,435
-522,525
| -50% | -$2.66M |
|
|
RPC
3893
Ridgepost Capital
RPC
$1B
| $2.76M | ﹤0.01% |
247,836
+245,400
| +10,074% | +$2.81M |
|
3894
Crawford & Co Class B
CRD.B
$506M
| $2.75M | ﹤0.01% |
390,490
+848
| +0.2% | +$6.2K |
|
3895
TriplePoint Venture Growth BDC
TPVG
$189M
| $2.75M | ﹤0.01% |
215,777
+29,610
| +16% | +$447K |
|
3896
Oil-Dri
ODC
$1.41B
| $2.74M | ﹤0.01% |
178,680
-446,466
| -71% | -$5.85M |
|
3897
Byrna Technologies
BYRN
$111M
| $2.73M | ﹤0.01% |
318,239
-844,147
| -73% | -$6.43M |
|
|
DBVT
3898
DBV Technologies
DBVT
$804M
| $2.72M | ﹤0.01% |
106,846
+38,112
| +55% | +$638K |
|
3899
MarketWise
MKTW
$53.6M
| $2.71M | ﹤0.01% |
37,717
+31,811
| +539% | +$2.21M |
|
|
OPTN
3900
DELISTED
OptiNose
OPTN
| $2.71M | ﹤0.01% |
49,419
-2,074
| -4% | -$76.3K |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.